- Home
- BMRA vs SILO Comparison
BMRA vs SILO Comparison
Compare BMRA & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- SILO
- Stock Information
- Founded
- BMRA 1971
- SILO 2010
- Country
- BMRA United States
- SILO United States
- Employees
- BMRA N/A
- SILO N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SILO Apparel
- Sector
- BMRA Health Care
- SILO Consumer Discretionary
- Exchange
- BMRA Nasdaq
- SILO Nasdaq
- Market Cap
- BMRA 8.2M
- SILO 8.0M
- IPO Year
- BMRA N/A
- SILO N/A
- Fundamental
- Price
- BMRA $2.96
- SILO $0.59
- Analyst Decision
- BMRA
- SILO
- Analyst Count
- BMRA 0
- SILO 0
- Target Price
- BMRA N/A
- SILO N/A
- AVG Volume (30 Days)
- BMRA 250.1K
- SILO 891.9K
- Earning Date
- BMRA 10-14-2025
- SILO 11-11-2025
- Dividend Yield
- BMRA N/A
- SILO N/A
- EPS Growth
- BMRA N/A
- SILO N/A
- EPS
- BMRA N/A
- SILO N/A
- Revenue
- BMRA $4,884,000.00
- SILO $72,102.00
- Revenue This Year
- BMRA N/A
- SILO $1.86
- Revenue Next Year
- BMRA N/A
- SILO N/A
- P/E Ratio
- BMRA N/A
- SILO N/A
- Revenue Growth
- BMRA N/A
- SILO N/A
- 52 Week Low
- BMRA $2.08
- SILO $0.40
- 52 Week High
- BMRA $10.16
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- BMRA 50.63
- SILO 44.12
- Support Level
- BMRA $2.82
- SILO $0.53
- Resistance Level
- BMRA $3.19
- SILO $0.58
- Average True Range (ATR)
- BMRA 0.20
- SILO 0.06
- MACD
- BMRA 0.02
- SILO -0.01
- Stochastic Oscillator
- BMRA 56.53
- SILO 58.92
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.